EUVIMEDEUVIMED entdecken
Crossref

Dual‐Mechanism mRNA Delivery via Fluorinated‐Sorbitol Polyplexes: Enhancing Cellular Uptake and Endosomal Escape for COVID‐19 Vaccination

Arathy Vasukutty, Sahil Chahal, Kyung-Hwa Lee, So-Hee Park, Soo-Min Kim, Eunkyung Shin, You-Jin Kim, Dokeun Kim, Jung-Ah Lee, Hye-Sook Jeong, In-Kyu Park iD

Advanced Healthcare Materials · 2025-03 · 14 (6)

DOI: 10.1002/adhm.202403374 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 26.12.2024. Verfasst von Arathy Vasukutty und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Biomedical Sciences Graduate Program (BMSGP), Chonnam National University Medical School, 322 Seoyang-ro, Hwasun, …. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, COVID-19 Vaccines, Endosomes. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advancements in mRNA delivery nanoparticles have significantly improved the potential for treating challenging diseases. Due to the inherent immunogenicity and rapid degradation of mRNA, specialized nanoparticles are required for efficient intracellular uptake, endosomal escape, and protection from lysosomal degradation. Although current methods enable transgene expression but achieving a balance between efficiency and toxicity remains challenging. In this study, an effective mRNA delivery system is developed by modifying a cationic polymer with sorbitol and fluorine, resulting in fluorinated polyethyleneimine with sorbitol functionalization (PFS). This polyplex enhances mRNA delivery through improved cellular uptake via sorbitol channels and caveolae‐mediated endocytosis, while fluorination facilitates endosomal escape and mitigates toxicity. The formulation demonstrated successful expression of Gaussian luciferase mRNA in both Raw 264.7 cells and Balb/c mice. Additionally, intramuscular administration of the SARS‐CoV‐2 spike mRNA vaccine elicited robust immune responses comparable to Moderna's LNP formulation. The vaccine effectively neutralized the Wuhan variant strain of SARS‐CoV‐2, as shown by PRNT 50 testing. These findings suggest that the PFS formulation is a promising candidate for developing polymeric mRNA vaccines targeting various infectious and non‐infectious diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19COVID-19 VaccinesEndosomesRNA, MessengerSorbitolAnimalsMiceMice, Inbred BALB CRAW 264.7 CellsNanoparticlesHumansFemaleVaccinationPolyethyleneimineSpike Glycoprotein, Coronavirus

Stichwörter der Autor:innen

SARS‐CoV‐2 spike mRNAlipid nanoparticlesmRNA deliverynano vaccinepolyethyleneimine‐sorbitol dimethacrylatepolyplex

Substanzen

COVID-19 VaccinesRNA, MessengerSorbitolPolyethyleneimineSpike Glycoprotein, Coronavirus

Autor:innen und Institutionen

  • Department of Biomedical Sciences, Biomedical Sciences Graduate Program (BMSGP), Chonnam National University Medical School, 322 Seoyang-ro, Hwasun, 58128, Republic of Korea.
  • Department of Pathology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, 322 Seoyang-ro, Hwasun, 58128, Republic of Korea.
  • Division of Infectious Disease Vaccine Research, Center for Vaccine Research, National Institute of Health, Cheong-Ju, CheongJu-si, Chungbuk, 28160, Republic of Korea.
  • Division of Vaccine Development Coordination, Center for Vaccine Research, National Institute of Health, Cheong-Ju, CheongJu, Chungbuk, 28160, Republic of Korea.
  • Division of Vaccine Clinical Research, Center for Vaccine Research, National Institute of Health, Cheong-Ju, CheongJu, Chungbuk, 28160, Republic of Korea.
  • DR Cure Inc., Hwasun, 58128, Republic of Korea.

ORCID-Profile: In-Kyu Park

Förderung

  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Vasukutty, A., Chahal, S., Lee, K. H., Park, S. H., Kim, S. M., Shin, E., Kim, Y. J., Kim, D., Lee, J. A., Jeong, H. S., & Park, I. K. (2025). Dual‐Mechanism mRNA Delivery via Fluorinated‐Sorbitol Polyplexes: Enhancing Cellular Uptake and Endosomal Escape for COVID‐19 Vaccination. Advanced Healthcare Materials, 14(6). https://doi.org/10.1002/adhm.202403374

Vancouver

Vasukutty A, Chahal S, Lee KH, Park SH, Kim SM, Shin E, et al. Dual‐Mechanism mRNA Delivery via Fluorinated‐Sorbitol Polyplexes: Enhancing Cellular Uptake and Endosomal Escape for COVID‐19 Vaccination. Advanced Healthcare Materials. 2025;14(6). doi:10.1002/adhm.202403374

BibTeX
@article{Vasukutty2025,
  author = {Vasukutty, Arathy and Chahal, Sahil and Lee, Kyung-Hwa and Park, So-Hee and Kim, Soo-Min and Shin, Eunkyung and Kim, You-Jin and Kim, Dokeun and Lee, Jung-Ah and Jeong, Hye-Sook and Park, In-Kyu},
  title = {Dual‐Mechanism mRNA Delivery via Fluorinated‐Sorbitol Polyplexes: Enhancing Cellular Uptake and Endosomal Escape for COVID‐19 Vaccination},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  volume = {14},
  number = {6},
  doi = {10.1002/adhm.202403374}
}
Kostenlos starten →